Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01823432 · ClinicalTrials.gov registry record
Genetic Risks for Bicuspid Aortic Valve Disease
A clinical trial, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- 454
- Enrollment target
NCT01823432: Completed study, sponsored by The University of Texas Health Science Center, Houston.
NCT01823432 is a clinical trial that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 454 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01823432 has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- 454 participants
- Enrollment target
Study Summary
Bicuspid Aortic Valve (BAV) is the most common congenital heart malformation in adults, but very little is known about the genetic causes or risk factors for adverse outcomes. Currently, it is estimated that most cases of aortic stenosis in patients less than 65 years old are caused by BAVs. BAV patients are also at high risk to develop aneurysms of the ascending aorta, which may lead to aortic dissections. Dr. Prakash and his colleagues plan to use individual genetic information to identify persons with BAV who are at high risk for complications and to customize therapies.
Primary Outcome
Development of new aneurysms and/or dissections of the thoracic aorta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 454 participants |
| Start Date | 2012-03 |
| Est. Completion | 2022-09-19 |
What the finished NCT01823432 record still lists
NCT01823432 is an observational study that tracks outcomes without assigning an intervention. The registered 454 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01823432 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01823432 about?
NCT01823432 is a clinical study titled "Genetic Risks for Bicuspid Aortic Valve Disease". Bicuspid Aortic Valve (BAV) is the most common congenital heart malformation in adults, but very little is known about the genetic causes or risk factors for adverse outcomes. Currently, it is estimated that most cases of aortic stenosis in patients less than 65 years old are caused by BAVs. BAV pat...
What is the current status of trial NCT01823432?
This trial is currently completed. The enrollment target is 454 participants. The study started on 2012-03. Estimated completion is 2022-09-19.
Who is sponsoring clinical trial NCT01823432?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05489211 · 454 participants · Phase 2
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- NCT05655936 · 454 participants · NA
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
- NCT06510374 · 454 participants · Phase 3
Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer
- NCT06935357 · 454 participants · Phase 3
A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia